Details
Stereochemistry | RACEMIC |
Molecular Formula | C21H23NO3.ClH |
Molecular Weight | 373.873 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.O=C(CCN1CCC(C1)C2=CC=CC=C2)C3=CC4=C(OCCO4)C=C3
InChI
InChIKey=QQZPGRDQMBPRFY-UHFFFAOYSA-N
InChI=1S/C21H23NO3.ClH/c23-19(17-6-7-20-21(14-17)25-13-12-24-20)9-11-22-10-8-18(15-22)16-4-2-1-3-5-16;/h1-7,14,18H,8-13,15H2;1H
Molecular Formula | C21H23NO3 |
Molecular Weight | 337.4122 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Proroxan is a non-selective а-adrenoblocker. Proroxan was found to prevent the development of hypertensive crises and improve cerebral bioelectrical parameters in most of hypertensive patients. Proroxan has been used as an antihypertensive and in the treatment
of Ménière’s disease, motion sickness, and allergic dermatitis.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2094251 |
|||
Target ID: CHEMBL2095158 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Pirroksan Approved UseProroxan has been used as an antihypertensive and in the treatment
of Ménière’s disease, motion sickness, and allergic dermatitis. |
|||
Primary | Pirroksan Approved UseProroxan has been used as an antihypertensive and in the treatment
of Ménière’s disease, motion sickness, and allergic dermatitis. |
|||
Primary | Pirroksan Approved UseProroxan has been used as an antihypertensive and in the treatment
of Ménière’s disease, motion sickness, and allergic dermatitis. |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:48:11 GMT 2023
by
admin
on
Fri Dec 15 15:48:11 GMT 2023
|
Record UNII |
694Z9P44G4
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29713
Created by
admin on Fri Dec 15 15:48:11 GMT 2023 , Edited by admin on Fri Dec 15 15:48:11 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
36302
Created by
admin on Fri Dec 15 15:48:11 GMT 2023 , Edited by admin on Fri Dec 15 15:48:11 GMT 2023
|
PRIMARY | |||
|
C009143
Created by
admin on Fri Dec 15 15:48:11 GMT 2023 , Edited by admin on Fri Dec 15 15:48:11 GMT 2023
|
PRIMARY | |||
|
300000044227
Created by
admin on Fri Dec 15 15:48:11 GMT 2023 , Edited by admin on Fri Dec 15 15:48:11 GMT 2023
|
PRIMARY | |||
|
C84120
Created by
admin on Fri Dec 15 15:48:11 GMT 2023 , Edited by admin on Fri Dec 15 15:48:11 GMT 2023
|
PRIMARY | |||
|
694Z9P44G4
Created by
admin on Fri Dec 15 15:48:11 GMT 2023 , Edited by admin on Fri Dec 15 15:48:11 GMT 2023
|
PRIMARY | |||
|
CHEMBL1395610
Created by
admin on Fri Dec 15 15:48:11 GMT 2023 , Edited by admin on Fri Dec 15 15:48:11 GMT 2023
|
PRIMARY | |||
|
33025-33-1
Created by
admin on Fri Dec 15 15:48:11 GMT 2023 , Edited by admin on Fri Dec 15 15:48:11 GMT 2023
|
PRIMARY | |||
|
DTXSID70954647
Created by
admin on Fri Dec 15 15:48:11 GMT 2023 , Edited by admin on Fri Dec 15 15:48:11 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |